Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Application

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 8, 2001, American Radiolabeled Chemical, Inc., 11624 Bowling Green Drive, St. Louis, Missouri 63146, made application by renewal and by letter dated May 2, 2001, to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

DrugSchedule
Gamma hydroxybutyric acid (2010)I
Lysergic acid diethylamide (7315)I
Dimethyltryptamine (7435)I
Dihydromophine (9145)I
Phencyclidine (7471)II
Cocaine (9041)II
Codeine (9050)II
Hydromorphone (9150)II
Oxycodone (9143)II
Thebaine (9333)II
Benzoylecgonine (9180)II
Meperidine (9230)II
Metazocine (9240)II
Morphine (9300)II
Oxymorphone (9652)II

The firm plans to bulk manufacture small quantities of the listed controlled substances as radiolabeled compounds.

Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than February 19, 2002.

Start Signature

Dated: November 15, 2001.

Laura M. Nagel,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 01-31408 Filed 12-20-01; 8:45 am]

BILLING CODE 4410-09-M